News

EFFERVESCENCE announce an initial list of speakers

IRICoR is delighted to announce the appointment of Catherine Bouchard as Chair of its Audit and Finance Committee

 
Since 2017, Catherine Bouchard sits on IRICoR’s Board of Directors on which she brings more than 10 years of experience in healthcare equity research. She is currently Head of Research, Life Sciences at the Caisse de dépôt et placement du Québec, where she has served as Senior Healthcare Analyst since 2012. Prior to joining CDPQ, Ms. Bouchard spent five years […]

CEO Competition – IRICoR and the Oncopole announced the awarding of 9 scholarships

Launch of the second cohort of the Life Sciences Entrepreneurship Development Program: IRICoR renews its participation with the Scholarship Competition – Entrepreneurship in Oncology (CEO)
 
Montréal, February 25, 2019 – On February 21st, in Montréal, a launch cocktail took place for the second cohort of the Life Sciences Entrepreneurship Development Program, where IRICoR and the […]

Launch of the new LeadAction|Breast Cancer du Sein Competition

A partnership between IRICoR and the Quebec Breast Cancer Foundation

 
For the past 10 years, IRICoR (Institute for Research in Immunology and Cancer – Commercialization of Research) has targeted the best academia-based projects in order to translate them into innovative therapies that will benefit patients. So far, IRICoR has made close to 80 financings in high-quality projects, established more than 20 […]

Special Lecture hosted by the IRIC and IRICoR

Promoting Tumor Dormancy of Breast Cancer Cells by ‘Normalizing’ their Microenvironment and their Malignant Phenotype
 
In May of 2017 and October of 2018, IRICoR took part in both economic missions in Israel in the Life Sciences sector organized by the Ministère de l’Économie, de la Science et de l’Innovation. During the course of the missions, IRICoR was able to exchange and forge […]

IRICoR broadens its ranks

IRICoR – Institute for Research in Immunology and Cancer – Commercialization of Research, the IRIC/Université de Montréal-based Canadian cancer drug discovery and commercialization cluster, is very pleased to announce the appointment as of today of Mrs. Violetta Dimitriadou as Vice-President, Scientific Operations and new member of IRICoR’s Management team. In this role, Mrs. Dimitriadou’s responsibilities will include developing the operational […]

Appointment of Jean-François Leprince as IRICoR’s Chairman of the Board

IRICoR is delighted about the appointment of Mr. Jean-François Leprince as its Chairman of the Board
 

 
Mr. Leprince joined IRICoR’s Board in 2009 as an Administrator. Over the past ten years, he has shown a strong commitment to IRICoR. He was notably involved in various activities related to the governance and recruitment of key people within the organization. More recently, he […]

EFFERVESCENCE – The future of life sciences

IRICoR is proud to be one of the 15 organizing partners of EFFERVESCENCE – The Future of Life Sciences
This major event developed for the life sciences and health technologies sector provides life sciences researchers, companies and stakeholders with a unique opportunity to network, build relationships business, participate in inspiring conferences and discover industry news, all in a stimulating experiential environment.
Inspired […]

Happy Holidays and Best Wishes

Steven Klein, guest speaker at the 2018 edition of the Genesis conference

 
On December 13th, 2018 Steven Klein, Vice President, Business Development at IRICoR, will take part in a discussion session as a guest speaker at Genesis 2018 in London. As part of the 18th Annual Genesis Conference, Steven Klein will be one of over 70 expert speakers and panellists will lead sessions discussing which approaches will deliver better outcomes for patients, investors and […]

« Previous Page | Next Page »